Candriam Equities L Oncology Impact I/  LU1864482515  /

Fonds
NAV2024-05-14 Chg.+3.4399 Type of yield Investment Focus Investment company
2,239.2500GBP +0.15% reinvestment Equity Worldwide Candriam